Genspera
San Antonio, US · Delaware corporation
Find your way into Genspera
Sign up to see every warm intro you have to Genspera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Genspera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CD
Craig DionneFounder
SO
Scott OgilvieExecutive
RR
Russell RichersonExecutive
Board
PG
Peter GrebowBoard director
BJ
Bo Jesper HansenBoard director
Reported raises · per SEC filings
Form D private placements$9.4M disclosed across 10 of 11 rounds · 2014–2021
▶$600KraisedJul 2021 · 2 investors · PharmaceuticalsRule 506(b)
▶$600KraisedJul 2021 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Claire ThomDirector
- Scott OgilvieDirector
- Offering amount
- $600K
- Amount sold
- $600K
- Minimum investment
- $100K
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedFeb 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$500KraisedFeb 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Scott OgilvieDirector
- Michael CainExecutive Officer, Director
- Claire ThomDirector
- Offering amount
- $500K
- Amount sold
- $500K
- Minimum investment
- $100K
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$600KraisedFeb 2021 · 3 investors · PharmaceuticalsRule 506(b)
▶$600KraisedFeb 2021 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Scott OgilvieDirector
- Michael CainExecutive Officer, Director
- Claire ThomDirector
- Offering amount
- $600K
- Amount sold
- $600K
- Minimum investment
- $100K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedFeb 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶Undisclosed amountofferedFeb 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Scott OgilvieDirector
- Michael CainExecutive Officer, Director
- Claire ThomDirector
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$320KraisedSep 2017 · 4 investors · PharmaceuticalsRule 506(b)
▶$320KraisedSep 2017 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Peter GrebowDirector
- Richard BullerDirector
- Ronald ShazerExecutive Officer
- John MontgomeryDirector
- Christopher LoweExecutive Officer, Director
- Scott OgilvieDirector
- Claire ThomDirector
- Offering amount
- $320K
- Amount sold
- $320K
- Minimum investment
- $20K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$290.4KraisedApr 2017 · 21 investors · PharmaceuticalsRule 506(b)
▶$290.4KraisedApr 2017 · 21 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christopher LoweExecutive Officer, Director
- Ronald ShazerExecutive Officer
- Claire ThomDirector
- Richard BullerDirector
- Peter GrebowDirector
- Bo Jesper HansenDirector
- Scott OgilvieDirector
- Offering amount
- $300K
- Amount sold
- $290.4K
- Minimum investment
- $3K
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedDec 2016 · 5 investors · PharmaceuticalsRule 506(b)
▶$1MraisedDec 2016 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Scott OgilvieDirector
- Christopher LoweExecutive Officer, Director
- Bo Jesper HansenDirector
- Claire ThomDirector
- Ronald ShazerExecutive Officer
- Russell RichersonExecutive Officer
- Richard BullerDirector
- Peter GrebowDirector
- Offering amount
- $1.2M
- Amount sold
- $1M
- Minimum investment
- $10K
- Sales commissions
- $120K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedJan 2016 · 4 investors · PharmaceuticalsRule 506(b)
▶$2.5MraisedJan 2016 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Scott OgilvieDirector
- Russell RichersonExecutive Officer
- Peter GrebowDirector
- Craig DionneExecutive Officer, Director
- Bo Jesper HansenDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Sales commissions
- $236.5K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Genspera?
- Genspera was founded by Craig Dionne.
- How much funding has Genspera raised?
- Genspera has disclosed $9.4M raised across 10 of its 11 known rounds.
- Where is Genspera headquartered?
- Genspera is headquartered in San Antonio, US.